Worldwide and European interest in the MitraClip: a Google Trends-based analysis.
The use of MitraClip (Abbott Vascular, Santa Clara, California, USA) for the treatment of severe functional mitral valve regurgitation (FMR) has drastically increased over recent years. We analysed the Worldwide and European interest on the MitraClip among Internet users performing a Google Trends-based analysis. We conducted a retrospective analysis extracting the data from the cited Google Trends (https://trends.google.com) to explore both the worldwide and European interest in the MitraClip over recent years. Specifically, Google Trends was queried from 1 January 2008 to 31 September 2019 using the item 'MitraClip'. Over the study period, the worldwide interest in the MitraClip steadily increased by 47.7% per month (Ptrend < 0.001). The analysis performed among the 11 European countries in which the search volume allowed a trend to be created over the study period confirming an increasing significant interest. Specifically, the higher rate of interest increase per month was registered in France followed by Poland, Spain and Italy (40.5, 35.9, 37.3 and 31.8%, respectively). A growing interest in the MitraClip exists both in Europe and worldwide.